Fusion of apoptosis‐related protein Cytochrome c with anti‐HER‐2 single‐chain antibody targets the suppression of HER‐2+ breast cancer

Cancer treatment has gradually developed from toxic chemotherapy to targeted therapy with fewer side effects. Approximately 30% of breast cancer patients overexpress human epidermal growth factor receptor 2 (HER‐2). Previous studies have successfully produced single‐chain antibodies (scFv) targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, DanDan, Guo, YiChen, Hu, YunFeng, Wang, Min, Li, Chen, Gangrade, Abhishek, Chen, JiaHui, Zheng, ZiHui, Guo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581304/
https://www.ncbi.nlm.nih.gov/pubmed/34697906
http://dx.doi.org/10.1111/jcmm.17001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581304/
https://www.ncbi.nlm.nih.gov/pubmed/34697906
http://dx.doi.org/10.1111/jcmm.17001

Ejemplares similares